Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joo-Hye Song

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|April 17, 2026
Clinical effects of ursodeoxycholic acid in COVID-19 infection: a systematic review and dose-response meta-analysisJoo Hye Song, Sung Ryul Shim, Jieun Shin, et al.
Nature Immunology|November 26, 2013
GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defensesHao-Sen Chiang, Yun Zhao, Joo-Hye Song, et al.
Plos One|May 16, 2013
Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammationXinhua Chen, Guoxun Yang, Joo-Hye Song, et al.
EMBO Reports|February 21, 2019
Gut microbiota regulates lacteal integrity by inducing VEGF-C in intestinal villus macrophagesSang Heon Suh, Kibaek Choe, Seon Pyo Hong, et al.
Inflammatory Bowel Diseases|June 1, 2023
One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort StudySung Noh Hong, Joo Hye Song, Sung Jin Kim, et al.
Scientific Reports|January 4, 2017
Microvasculature remodeling in the mouse lower gut during inflammagingJae-Ho Jeong, KwangSoo Kim, Daejin Lim, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2024
Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's DiseaseSung Noh Hong, Joo Hye Song, Sung Jin Kim, et al.
Gastroenterology|February 14, 2015
SLAMF4 Is a Negative Regulator of Expansion of Cytotoxic Intraepithelial CD8+ T Cells That Maintains Homeostasis in the Small IntestineMichael S O'Keeffe, Joo-Hye Song, Gongxian Liao, et al.
Inflammatory Bowel Diseases|September 3, 2011
Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1Yun Zhao, Carmen Alonso, Isabel Ballester, et al.
Inflammatory Bowel Diseases|April 9, 2022
Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1Gyeol Seong, Joo Hye Song, Ji Eun Kim, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|April 17, 2026
Clinical effects of ursodeoxycholic acid in COVID-19 infection: a systematic review and dose-response meta-analysisJoo Hye Song, Sung Ryul Shim, Jieun Shin, et al.
Nature Immunology|November 26, 2013
GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defensesHao-Sen Chiang, Yun Zhao, Joo-Hye Song, et al.
Plos One|May 16, 2013
Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammationXinhua Chen, Guoxun Yang, Joo-Hye Song, et al.
EMBO Reports|February 21, 2019
Gut microbiota regulates lacteal integrity by inducing VEGF-C in intestinal villus macrophagesSang Heon Suh, Kibaek Choe, Seon Pyo Hong, et al.
Inflammatory Bowel Diseases|June 1, 2023
One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort StudySung Noh Hong, Joo Hye Song, Sung Jin Kim, et al.
Scientific Reports|January 4, 2017
Microvasculature remodeling in the mouse lower gut during inflammagingJae-Ho Jeong, KwangSoo Kim, Daejin Lim, et al.
Alimentary Pharmacology & Therapeutics|November 18, 2024
Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's DiseaseSung Noh Hong, Joo Hye Song, Sung Jin Kim, et al.
Gastroenterology|February 14, 2015
SLAMF4 Is a Negative Regulator of Expansion of Cytotoxic Intraepithelial CD8+ T Cells That Maintains Homeostasis in the Small IntestineMichael S O'Keeffe, Joo-Hye Song, Gongxian Liao, et al.
Inflammatory Bowel Diseases|September 3, 2011
Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1Yun Zhao, Carmen Alonso, Isabel Ballester, et al.
Inflammatory Bowel Diseases|April 9, 2022
Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1Gyeol Seong, Joo Hye Song, Ji Eun Kim, et al.
Pageof 6